Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP194328.RAyFKVlC_IO40Dg9cD-ikPzpH0Tq7Z5Nc6E4SmveLsyok130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP194328.RAyFKVlC_IO40Dg9cD-ikPzpH0Tq7Z5Nc6E4SmveLsyok130_assertion type Assertion NP194328.RAyFKVlC_IO40Dg9cD-ikPzpH0Tq7Z5Nc6E4SmveLsyok130_head.
- NP194328.RAyFKVlC_IO40Dg9cD-ikPzpH0Tq7Z5Nc6E4SmveLsyok130_assertion description "[In this study, BLyS levels were measured before and after 4 weekly doses of rituximab in 30 patients with previously untreated follicular Grade 1 NHL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP194328.RAyFKVlC_IO40Dg9cD-ikPzpH0Tq7Z5Nc6E4SmveLsyok130_provenance.
- NP194328.RAyFKVlC_IO40Dg9cD-ikPzpH0Tq7Z5Nc6E4SmveLsyok130_assertion evidence source_evidence_literature NP194328.RAyFKVlC_IO40Dg9cD-ikPzpH0Tq7Z5Nc6E4SmveLsyok130_provenance.
- NP194328.RAyFKVlC_IO40Dg9cD-ikPzpH0Tq7Z5Nc6E4SmveLsyok130_assertion SIO_000772 19051265 NP194328.RAyFKVlC_IO40Dg9cD-ikPzpH0Tq7Z5Nc6E4SmveLsyok130_provenance.
- NP194328.RAyFKVlC_IO40Dg9cD-ikPzpH0Tq7Z5Nc6E4SmveLsyok130_assertion wasDerivedFrom befree-20140225 NP194328.RAyFKVlC_IO40Dg9cD-ikPzpH0Tq7Z5Nc6E4SmveLsyok130_provenance.
- NP194328.RAyFKVlC_IO40Dg9cD-ikPzpH0Tq7Z5Nc6E4SmveLsyok130_assertion wasGeneratedBy ECO_0000203 NP194328.RAyFKVlC_IO40Dg9cD-ikPzpH0Tq7Z5Nc6E4SmveLsyok130_provenance.